1. [O2–17–02]: DISCOVERY AND EARLY CLINICAL DEVELOPMENT OF IONIS‐MAPTRX, THE FIRST TAU‐LOWERING ANTISENSE OLIGONUCLEOTIDE, IN PATIENTS WITH MILD AD. (1st July 2017) Authors: Lane, Roger M.; Kordasiewicz, Holly B.; Smith, Anne; Mignon, Laurence; Miller, Timothy M.; Mummery, Catherine J.; Andreasen, Niels; Narayanan, Padma; Swayze, Eric; Norris, Daniel A.; Fitzsimmons, Bethany; Bennett, C Frank Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 12 Page Start: P600 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [P2–211]: AMYLOID‐β42 (Aβ42) DIFFERENTIALLY CORRELATES WITH CSF TOTAL AND HYPERPHOSPHORYLATED TAU IN AN AMYLOID‐POSITIVE VERSUS AMYLOID‐NEGATIVE EARLY PRODROMAL AND ASYMPTOMATIC AT‐RISK FOR AD POPULATION. (1st July 2017) Authors: Tesseur, Ina; Timmers, Maarten; Borjesson, Anne; Van Broeck, Bianca; Slemmon, J Randall; Smekens, Pascale; Aguilar, Miguel; Baquero, Miguel; Frank, Anna; Matias‐Guiu, Jorge; Boada, Mercè; Hugon, Jacques; Prins, Niels D.; Laske, Christoph; Tritsmans, Luc; Van Nueten, Luc; Andreasen, Niels; Zetterb... Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 14 Page Start: P690 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease. Issue 10 (19th December 2014) Authors: Kvartsberg, Hlin; Duits, Flora H.; Ingelsson, Martin; Andreasen, Niels; Öhrfelt, Annika; Andersson, Kerstin; Brinkmalm, Gunnar; Lannfelt, Lars; Minthon, Lennart; Hansson, Oskar; Andreasson, Ulf; Teunissen, Charlotte E.; Scheltens, Philip; Van der Flier, Wiesje M.; Zetterberg, Henrik; Portelius, E... Journal: Alzheimer's & dementia Issue: Volume 11:Issue 10(2015) Page Start: 1180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease. Issue 11 (9th February 2015) Authors: Karami, Azadeh; Eyjolfsdottir, Helga; Vijayaraghavan, Swetha; Lind, Göran; Almqvist, Per; Kadir, Ahmadul; Linderoth, Bengt; Andreasen, Niels; Blennow, Kaj; Wall, Anders; Westman, Eric; Ferreira, Daniel; Kristoffersen Wiberg, Maria; Wahlund, Lars‐Olof; Seiger, Åke; Nordberg, Agneta; Wahlberg, Lars... Journal: Alzheimer's & dementia Issue: Volume 11:Issue 11(2015) Page Start: 1316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid. (28th June 2010) Authors: Bjerke, Maria; Portelius, Erik; Minthon, Lennart; Wallin, Anders; Anckarsäter, Henrik; Anckarsäter, Rolf; Andreasen, Niels; Zetterberg, Henrik; Andreasson, Ulf; Blennow, Kaj Other Names: Parnetti Lucilla Academic Editor. Journal: International journal of alzheimer's disease Issue: Volume 2010(2010) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. IC‐P‐108: VOLUMETRIC MRI RESULTS OF BMS AVAGACESTAT IN A PRODROMAL AD POPULATION. (1st July 2014) Authors: Istace, Audrey; Bracoud, Luc; Berman, Robert M.; Luo, Feng; Roche, Florent; Salloway, Stephen; van Dyck, Christopher; Dubois, Bruno; Andreasen, Niels; Brody, Mark; Curtis, Craig; Soininen, Hilkka; Thein, Stephen; Shiovitz, Thomas; Ferris, Steven H.; Grill, Joshua D.; Gouttard, Sylvain; Schaerer, ... Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 6 Page Start: P60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of cerebrospinal fluid matrix on the detection of Alzheimer's disease with Aβ42 and influence of disease on the total‐Aβ42/Aβ40 ratio. (29th September 2015) Authors: Slemmon, J. Randall; Shapiro, Alice; Mercken, Marc; Streffer, Johannes; Romano, Gary; Andreasen, Niels; Zetterberg, Henrik; Blennow, Kaj Journal: Journal of neurochemistry Issue: Volume 135:Number 5(2015:Dec.) Page Start: 1049 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Neuroinflammation Screening in Immunotherapy Trials against Alzheimer's Disease. (6th December 2010) Authors: Andreasen, Niels; Blennow, Kaj; Zetterberg, Henrik Other Names: Takashima Akihiko Academic Editor. Journal: International journal of alzheimer's disease Issue: Volume 2010(2010) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. O1–09–06: The 'CSF Alzheimer's profile': Easily said, but what do we mean?. (1st July 2013) Authors: Duits, Flora; Teunissen, Charlotte; Bouwman, Femke; Visser, Pieter Jelle; Mattsson, Niklas; Zetterberg, Henrik; Blennow, Kaj; Hansson, Oskar; Minthon, Lennart; Andreasen, Niels; Marcusson, Jan; Wallin, Anders; Olde Rikkert, Marcel; Tsolaki, Magda; Parnetti, Lucilla; Herukka, Sanna‐Kaisa; Hampel, ... Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 4 Page Start: P147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P1‐364: ACTIVE AB IMMUNOTHERAPY CAD106 PHASE II DOSE‐ADJUVANT FINDING STUDY: IMMUNE RESPONSE. (1st July 2014) Authors: Riviere, Marie‐Emmanuelle; Caputo, Angelika; Laurent, Nathalie; Vostiar, Igor; Andreasen, Niels; Cohen, Sharon; Kressig, Reto W.; Ryan, J. Michael; Graf, Ana Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 11 Page Start: P447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗